Again, that was in the context of Bill C-45 and I would be happy to circulate to the committee a compilation of testimonies from companies from across the country that gave me their comments about how SR and ED changes would impact R and D in their businesses. I'd be happy to circulate that to the committee members.
On November 6th, 2012. See this statement in context.